Investors are eager for the Benchling IPO. The company made headlines when it confidentially filed with the SEC to go public. Biotechnology is rewriting life as we know it. Our customers, spanning ...

Benchling’s unicorn status didn’t come overnight. Some 10 years after its founding, the company is worth more than $6 billion, and the founder sees the company going public in the future. The ...

Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a software framework that helps bring Merck's pre-clinical and clinical ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...

Antibody R&D teams can configure any format in minutes and register up to 1,000 antibodies in a single run Benchling Biologics is the end-to-end platform for antibody R&D, giving teams the AI-ready ...

Benchling is a next-gen laboratory informatics platform that is helping life science companies manage increasingly complex data workflows. GEN Edge talks to CEO/co-founder Saji Wickramasekara and ...

Last year, Benchling raised $200 million through a series E round to help expand its digital platform followed by a $100 million series F just over six months later ...